Claims for Patent: 9,097,628

Summary for Patent: 9,097,628

Title:	Method and kit for processing wax-embedded biological samples
Abstract:	The present invention relates to a method for processing a wax-embedded biological sample, the use of poly(organosiloxane)s for liquefying the embedding medium of a wax-embedded biological sample and a kit for processing a wax-embedded biological sample.
Inventor(s):	Schlumpberger; Martin (Hilden, DE)
Assignee:	QIAGEN, GMbH (Hilden, unknown)
Application Number:	13/996,437
Patent Claims:	1. A method for processing a wax-embedded biological sample that comprises a biological sample and wax as an embedding medium, comprising: (1) liquefying the embedding medium by exposing the embedded biological sample to a de-waxing agent to obtain a de-waxed sample and a liquefied embedded medium, wherein the de-waxing agent comprises a poly(organosiloxane) or a mixture of poly(organosiloxane)s. 2. The method of claim 1, wherein the wax-embedded biological sample is selected from the group consisting of embedded tissues and cells. 3. The method of claim 2, wherein the wax-embedded biological sample is a paraffin-embedded sample. 4. The method of claim 2, wherein the wax-embedded biological sample is a formalin-fixed paraffin-embedded sample (FFPE-sample). 5. The method of claim 1, wherein the de-waxing agent has a boiling point above 75.degree. C. 6. The method of claim 5, wherein the de-waxing agent has a boiling point above 90.degree. C. 7. The method of claim 6, wherein the de-waxing agent has a boiling point above 120.degree. C. 8. The method of claim 7, wherein the de-waxing agent has a boiling point above 140.degree. C. 9. The method of claim 1, wherein the de-waxing agent has a kinematic viscosity of equal to or less than 5 mm.sup.2s.sup.-1. 10. The method of claim 9, wherein the de-waxing agent has a kinematic viscosity of equal to or less than 3 mm.sup.2s.sup.-1. 11. The method of claim 10, wherein the de-waxing agent has a kinematic viscosity of equal to or less than 2 mm.sup.2s.sup.-1. 12. The method of claim 11, wherein the de-waxing agent has a kinematic viscosity of equal to or less than 1.5 mm.sup.2s.sup.-1. 13. The method of claim 1, wherein the poly(organosiloxane)(s) is (are) selected from the group consisting of linear poly(organosiloxane)s. 14. The method of claim 13, wherein the poly(organosiloxane)(s) is (are) trialkylsiloxy-terminated polydialkylsiloxanes wherein "alkyl" comprises linear or branched C.sub.1, C.sub.2, C.sub.3, C.sub.4 C.sub.5 or C.sub.6 hydrocarbon chains. 15. The method of claim 14, wherein the poly(organosiloxane)(s) is (are) selected from the group consisting of linear trimethylsiloxy-terminated poly(dimethylsiloxane)s of the formula CH.sub.3[Si(CH.sub.3).sub.2O].sub.nSi(CH.sub.3).sub.3, wherein the number of repeating units n is in the range of from 1 to 5. 16. The method of claim 15, wherein the poly(organosiloxane) is octamethyltrisiloxane (n=2). 17. The method of claim 1, wherein the step of exposing the embedded biological sample to a de-waxing agent comprises incubating the embedded biological sample in the presence of the de-waxing agent at a temperature in the range of from 15 to 95.degree. C. 18. The method of claim 17, wherein the step of exposing the embedded biological sample to a de-waxing agent comprises incubating the embedded biological sample in the presence of the de-waxing agent at a temperature in the range of from 20 to 75.degree. C. 19. The method of claim 18, wherein the step of exposing the embedded biological sample to a de-waxing agent comprises incubating the embedded biological sample in the presence of the de-waxing agent at a temperature in the range of from room temperature (23+/-2.degree. C.) to 65.degree. C. 20. The method of claim 1, further comprising: (2) exposing the mixture obtained in step (1) to an aqueous solution, thereby partitioning the liquefied embedding medium and the de-waxed biological sample. 21. The method of claim 20, wherein the aqueous solution is an aqueous lysis buffer, and lysis of the de-waxed biological sample is carried out in the presence of the de-waxing agent and the liquefied embedding medium to obtain a lysed biological sample. 22. The method of claim 21, wherein the aqueous lysis buffer comprises at least one buffering substance and a detergent. 23. The method of claim 21, wherein the lysis of the de-waxed biological sample is carried out by incubating the mixture obtained in step (2) at a temperature or a succession of temperature steps in the range of from 15 to 95.degree. C. or from 20 to 90.degree. C. 24. The method of claim 23, wherein the lysis of the de-waxed biological sample is carried out by incubating the mixture obtained in step (2) for a time period of from 1 minute to 24 hours, from 5 minutes to 12 hours, or from 15 minutes to 3 hours. 25. The method of claim 21, wherein either the aqueous lysis buffer additionally comprises a proteolytic agent or a proteolytic agent is added to the mixture obtained in step (2), said proteolytic agent being selected from the group consisting of proteases and non-enzymatic proteolytic compounds. 26. The method of claim 21, wherein the proteolytic agent is selected from the group consisting of proteinase K, trypsin, chymotrypsin, papain, pepsin, pronase, endoproteinase Lys-C, alpha-lytic proteinase, elastase, collegenase, bromocyane, recombinant Bacillus proteases, Lysozyme, and mixtures thereof. 27. The method of claim 21, further comprising: (3) reducing the number of remaining cross-linkings in the sample. 28. The method of claim 27, wherein step (3) is carried out by heating the mixture of the aqueous lysis buffer and the de-waxing agent to a temperature of about 70-95.degree. C. and/or by adding to said mixture a cross-linking removal agent, comprising at least one nucleophilic reagent. 29. The method of claim 21, further comprising: (4) optionally separating the aqueous phase from the de-waxing agent and the liquefied embedding medium, and (5) selectively isolating at least one class of biomolecules selected from the group consisting of proteins, RNA and DNA from the lysed biological sample. 30. The method of claim 29, wherein the at least one class of biomolecules are RNA and/or DNA. 31. The method of claim 29, wherein step (5) comprises at least one chromatographic and/or solid phase-based purification or precipitation step. 32. The method of claim 31, wherein the at least one chromatographic and/or solid phase-based purification or precipitation step is selected from the group consisting of (a) gel filtration chromatography, (b) ion exchange chromatography, (c) reversed phase chromatography, and (d) precipitating and simultaneously binding the at least one class of biomolecules to a solid phase. 33. The method of claim 20, wherein the aqueous solution is an aqueous staining solution, comprising a dye or a substance that binds to a certain type of cell and/or cell component. 34. The method of claim 33, wherein the dye or the substance is selected from the group consisting of acridine dyes, anthraquinone dyes, arylmethane dyes, azo dyes, diazonium dyes, nitro dyes, phthalocyanine dyes, quinine imine dyes, tetrazolium dyes, thiazole dyes, xanthene dyes, hematoxylin, eosin, and mixtures thereof. 35. A kit for processing a wax-embedded biological sample, comprising: (1) a de-waxing agent that comprises a poly(organosiloxane) or a mixture of poly(organosiloxane)s, (2) an aqueous solution for partitioning a de-waxed sample and a liquefied embedding medium, wherein the aqueous solution is (a) an aqueous lysis buffer comprising a proteolytic agent, or (b) an aqueous staining solution comprising a dye or a substance that binds to a certain type of cell or cell component, and (3) a chromatographic device and/or a solid phase for isolating at least one class of biomolecules. 36. The kit of claim 35, wherein the poly(organosiloxane)(s) is (are) poly(organosiloxane)s that a) has (have) a boiling point above 75.degree. C., above 90.degree. C., above 120 .degree. C., or above 140.degree. C., b) has (have) a kinematic viscosity of equal to or less than 5 mm.sup.2s.sup.-1, equal to or less than 3 mm.sup.2s.sup.-1, equal to or less than 2 mm.sup.2s.sup.-1, or equal to or less than 1.5 mm.sup.2s.sup.-1, and/or c) (i) is (are) selected from the group consisting of linear poly(organosiloxane)s, (ii) is (are) trialkylsiloxy-terminated polydialkylsiloxanes wherein "alkyl" comprises linear or branched C.sub.1, C.sub.2, C.sub.3, C.sub.4 C.sub.5 or C.sub.6 hydrocarbon chains, (iii) is (are) selected from the group consisting of linear trimethylsiloxy-terminated poly(dimethylsiloxane)s of the formula CH.sub.3[Si(CH.sub.3).sub.2O].sub.n,Si(CH.sub.3).sub.3, wherein the number of repeating units n is in the range of from 1 to 5, and/or (iv) is octamethyltrisiloxane (n=2). 37. The kit of claim 35, wherein the aqueous solution is an aqueous lysis buffer, and has one or more of the following features: a) the aqueous lysis buffer further comprises at least one buffering substance and a detergent, b) the proteolytic agent is a non-enzymatic proteolytic compound, and c) the proteolytic agent is a protease selected from the group consisting of proteinase K, trypsin, chymotrypsin, papain, pepsin, pronase, endoproteinase Lys-C, alpha-lytic proteinase, elastase, collagenase, bromocyane, recombinant Bacillus proteases, Lysozyme, and mixtures thereof. 38. The kit of claim 35, wherein the chromatographic device and/or solid phase is a chromatographic device and/or solid phase for carrying out a step selected from the group consisting of (a) gel filtration chromatography, (b) ion exchange chromatography, (c) reversed phase chromatography, and (d) precipitating and simultaneously binding the at least one class of biomolecules to the solid phase.

Details for Patent 9,097,628

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2030-12-23